Hydroxyapatite toothpaste: does it actually work?
There is real clinical evidence that it remineralises early enamel damage, in several trials about as well as fluoride. That evidence is also smaller, younger, and largely funded by the companies selling it.
Probably, for early damage — and the honest version of that answer needs both halves. Hydroxyapatite toothpaste has better clinical evidence behind it than almost anything else sold as a fluoride alternative. It also has far less evidence than fluoride, and much of what exists was paid for by a company that sells it. Neither of those facts cancels the other out.
What hydroxyapatite actually is
Enamel is almost entirely mineral — roughly 96% by weight — and that mineral is hydroxyapatite, a crystalline calcium phosphate. The synthetic hydroxyapatite in a toothpaste is the same crystal species as the one your teeth are built from.
Which is why the marketing writes itself: brush with what your teeth are made of. It is also why the idea deserves to be taken seriously rather than waved away. Enamel is not inert. It loses mineral to acid and takes it back from saliva continuously, a cycle covered in the oral microbiome guide. A paste that supplies the mineral in the form enamel already uses is a plausible intervention, not a gimmick.
Plausible is where the argument starts, though, not where it finishes.
What the evidence shows
Three studies do most of the work in this debate. It is worth knowing what each one actually is, because at least one of them is routinely described as something it is not.
| Study | What it actually was | What it found |
|---|---|---|
| Paszynska et al. 2023 Front Public Health 11:1199728 |
18-month double-blinded randomised trial, 189 adults aged 18–45, two centres in Poland. 10% hydroxyapatite vs 1,450 ppm fluoride. | 89.3% vs 87.4% of people had no increase in decayed, missing or filled surfaces. Hydroxyapatite was not statistically inferior. |
| Amaechi et al. 2019 BDJ Open 5:18 |
Not a children’s trial. An in situ crossover study: 30 adults, mean age 39.5, wearing appliances holding primary-tooth enamel specimens with laboratory-made lesions. 14 days per arm. | Both pastes remineralised over 50% and cut lesion depth by over 25%, with no significant difference between them. |
| Pawinska et al. 2024 J Dent 151:105429 |
Systematic review and meta-analysis pooling 5 clinical trials and 8 in situ trials. | Concluded the evidence has expanded and that hydroxyapatite works as an anti-caries ingredient without fluoride. |
The middle row matters. That 2019 study is widely cited as evidence that hydroxyapatite prevents cavities in children. It measured enamel specimens carried in the mouths of adults for a fortnight. That is a legitimate and standard design — but it tells you about mineral moving in and out of a chip of enamel, not about whether any child got fewer fillings.
What “non-inferior” actually means
Both the 18-month trial and the 2019 study were built as non-inferiority tests, and this is the single most misread thing about them.
Non-inferiority does not mean “as good as”. It means “not worse by more than a margin we set in advance”. In the 18-month trial that margin was 20%. A result can clear a 20% margin while still being somewhat worse than the comparator — that is the design working as intended, not a flaw in it.
So “proven as effective as fluoride”, which is roughly how this gets sold, is a stronger sentence than the trials were built to produce.
Who paid for the research
Look at this before you look at any result.
The 18-month trial states its funding plainly, and to its credit does so in the paper itself: “This research was funded by Dr. Kurt Wolff GmbH & Co. KG, Bielefeld, Germany”, along with the two universities involved. Dr Kurt Wolff manufactures hydroxyapatite toothpaste. Three of the paper’s authors are disclosed as employees of that company.
The 2019 study declares no competing interests and names no funder at all. The hydroxyapatite paste it tested was made by the same company.
And the 2024 systematic review — the one usually invoked as the top of the evidence pyramid — has six authors. Two are employees of that company. Three others wrote the trials the review pools. A systematic review is meant to be an independent appraisal of a body of literature. This one substantially is the body of literature it appraises.
This is disclosure, not an accusation
Everything above is printed in the papers themselves. Nobody hid it, and industry funds a large share of all oral-care research — refusing to read anything a manufacturer paid for would mean refusing to read most of the field. The trials look competently designed and were properly registered and blinded.
What it changes is what you should wait for. When the people running the trials, pooling the trials and selling the product overlap this heavily, the thing that would settle the question is independent replication — and that is exactly what is still thin.
What the independent appraisals say
They are noticeably cooler than the review, and there are three of them.
- A 2025 commentary in Evidence-Based Dentistry re-examined the 2024 meta-analysis. Hydroxyapatite clearly beat placebo. Against fluoride, the pooled odds ratio was 1.1 and not statistically significant — and the pooled in situ remineralisation difference, a mean change of 2.8%, was not significant either.
- A separate 2025 systematic review in the Journal of Dentistry, by an unrelated group, applied stricter inclusion criteria. Of 68 studies retrieved, four qualified. Its meta-analysis found no significant difference, and it concluded hydroxyapatite “could be” an effective alternative.
- A 2026 scoping review in the European Journal of Pediatrics looked at fluoride-free options generally: 122 studies, only 20 offering direct evidence in children, most of it laboratory work. Its verdict was that no fluoride-free category yet has evidence comparable to fluoride for long-term cavity prevention in children — while noting hydroxyapatite had the most consistent data of the alternatives.
Every independent look lands on the same shape of answer: promising, plausibly comparable, not demonstrated equal.
Hydroxyapatite versus fluoride, honestly
They do different things. Fluoride is taken up into the enamel surface and forms fluorapatite, a crystal more resistant to acid than the original — it changes what the surface is made of. Hydroxyapatite deposits mineral onto and into the surface, topping up what was lost. One hardens the target; the other refills it.
Fluoride’s evidence base is not somewhat larger. It is larger by orders of magnitude, across decades, and it remains one of the most thoroughly evidenced interventions in dentistry. Nothing on this page is an argument for giving it up. If you use a fluoride toothpaste and your check-ups go well, there is no finding here that should change your mind.
There is one narrow, real exception, and it concerns swallowing rather than brushing. Repeatedly swallowing fluoride toothpaste while the permanent teeth are still forming is associated with dental fluorosis. Standard dental guidance addresses that by controlling the amount and supervising young children, not by avoiding fluoride. Hydroxyapatite, by contrast, is considered safe if swallowed — which is a genuine advantage in exactly one situation, discussed below.
Nano versus micro
Some pastes use nanoparticle hydroxyapatite, some larger particles, and “nano” gets deployed in both directions — as a selling point and as a scare.
The European Commission’s Scientific Committee on Consumer Safety looked at the nano form specifically. Its opinion SCCS/1677/25, adopted 26 June 2025, concluded that hydroxyapatite (nano) is safe at up to 29.5% in toothpaste and 10% in mouthwash. That is a substantial increase on its own 2023 opinion, which had set the limits at 10% and 0.465%.
So the regulator scrutinised it closely and became more permissive, not less. That runs opposite to how “nano” is usually deployed in wellness marketing.
The conditions are worth knowing, though. The opinion applies only to rod-shaped, uncoated, unmodified particles, and states explicitly that it “is not applicable to any hydroxyapatite (nano) material that is composed of or contains needle-shaped particles”. Which is a meaningful caveat and an unusable one for a shopper: no box tells you its particle aspect ratio.
The marketing around it
The claims worth recognising when you meet them:
- “Non-toxic” — a phrase that only carries weight if you accept what it implies about the alternative, at a dose you spit out.
- “Fluoride-free” presented as a safety feature rather than as a description of what is absent.
- “Clinically proven” attached to a non-inferiority result — see above for the gap between those two things.
- The price. Hydroxyapatite pastes commonly cost several times a fluoride paste. Against fluoride specifically, the evidence does not currently justify that premium.
This site recommends no brands and links to no products, here or anywhere. The search results for this topic are close to wall-to-wall affiliate listicles; carrying none of that is the point.
Who might reasonably choose it
- Young children who swallow toothpaste The clearest case, and the one the evidence best supports. Hydroxyapatite is considered safe if swallowed, which removes the fluorosis calculation entirely. Worth raising with your dentist rather than deciding alone.
- People who have already decided against fluoride If that decision is made, this is a far better destination than a paste with no remineralising agent in it at all. Better hydroxyapatite than nothing is a low bar, but it is a real one.
- People with sensitive teeth Hydroxyapatite is marketed hard for sensitivity and the evidence is modest rather than strong. If this is your reason, read what causes sensitive teeth first — the cause usually matters more than the paste.
What it will not do
- It will not fill a cavity. Once the surface has collapsed there is no scaffold left to rebuild on — see can teeth remineralise? for where that line actually falls.
- It will not remove plaque. Plaque is a film stuck to a surface and it comes off mechanically or not at all — see plaque vs tartar.
- It will not whiten your teeth beyond the surface polish any paste gives. See what actually whitens teeth.
- It will not make technique optional. Two minutes, every surface, something between the teeth once a day. No paste substitutes for that.
Where supplements fit
Calcium phosphates turn up in oral-health supplements too, which invites an obvious leap: if the mineral helps enamel, surely swallowing it helps more. It does not follow. Remineralisation happens at the surface of a tooth, from saliva in contact with it — a mineral that goes down your throat is not in the place where the work happens. If you want the category assessed on its own terms, do oral probiotics actually work? covers what the research supports and where it stops.
When to see someone
A visible hole, a white or brown spot that is spreading, sensitivity that has changed, or any pain. None of those is a toothpaste decision. An early lesion and a cavity look far more alike to a reader than to a dentist, and only one of them is still reversible — which is precisely why guessing is the wrong move.